Article Details

TRACON Pharmaceuticals (NASDAQ:TCON) Receives Buy Rating from HC Wainwright

Retrieved on: 2020-01-25 21:30:00

Tags for this article:

Click the tags to see associated articles and topics

TRACON Pharmaceuticals (NASDAQ:TCON) Receives Buy Rating from HC Wainwright. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC boosted its stake in TRACON Pharmaceuticals by 17.5% during the second quarter. <b>Renaissance Technologies</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up